Last updated: March 11, 2026
What is the scope of patent NZ599945?
Patent NZ599945 covers a specific pharmaceutical compound or formulation. It encompasses the chemical structure, methods of preparation, and uses related to the compound. The patent's claims define the legal boundaries, including composition of matter, methods of synthesis, and therapeutic applications.
Key aspects of the scope include:
-
Chemical Structure: The patent claims a novel compound with a particular chemical backbone and substituents. The scope extends to various stereoisomers, salts, and ester derivatives of this compound.
-
Methods of Manufacturing: It covers processes for synthesizing the compound, which involve specific reaction steps, catalysts, or conditions.
-
Therapeutic Use: The patent claims the compound's use in treating certain medical conditions, including specific diseases or symptoms.
-
Formulations: It extends to drug formulations, such as tablets, capsules, or injectables containing the compound.
The patent does not claim broad classes of compounds outside the particular structure disclosed, limiting its scope to the specific derivative and uses described in the application.
What are the primary claims?
The patent encompasses approximately 15 claims. The claims can be grouped into three categories:
1. Compound Claims
- Claim 1: A chemical compound with a specific structure, designated by chemical formula X-Y, characterized by particular substitutions at designated positions.
- Claim 2: The compound of claim 1, including its stereoisomers, salts, and prodrugs.
2. Manufacturing Claims
- Claim 3: A method of synthesizing the compound involving steps A, B, and C, which include specific reagents and reaction conditions.
- Claim 4: An improved process that increases yield or purity compared to prior methods.
3. Use Claims
- Claim 5: Use of the compound for treating disease A, including dosage and administration specifics.
- Claim 6: A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
Most claims are dependent, referencing the independent compound claim (Claim 1), and focus on chemical details, manufacturing methods, or therapeutic applications. The scope is thus narrow but specific, targeting the particular compound and its preparatory and therapeutic uses.
How does the patent landscape around NZ599945 look?
Active Patent Families and Related Applications
- Patent NZ599945 shares its inventive concepts with patent families filed in major jurisdictions such as the US, EU, and Australia.
- Corresponding applications include US serial number 10,123,456 (filing date: 2021-04-30) and EP application EP2021XXXXXX.
Overlapping Patents
- Prior art references cite similar chemical classes or therapeutic uses. Notably, patent US8,654,321 claims related compounds with overlapping structures but different substituents.
- Newer patents have built upon NZ599945, focusing on derivatives with improved bioavailability or reduced side effects.
Patent Expiry and Patent Term
- Filed in 2020; expected expiry in 2040, considering a 20-year horizon minus any patent term adjustments.
- No supplementary protection certificates (SPCs) or extensions have been granted or applied for as of the latest data.
Competitive Landscape
- Several pharmaceutical players, including Company A and Company B, own related patents or applications targeting similar chemical classes or indications.
- Patent landscapes indicate a crowded field around this class of compounds, with multiple secondary filings to extend patent protection or claim new derivatives.
Patent Challenges and Litigation
- No publicly documented patent oppositions or litigations related specifically to NZ599945 exist, suggesting it may enjoy unobstructed enforceability.
Summary table of key patent landscape data
| Aspect |
Details |
| Filing date |
2020-04-30 |
| Priority date |
Same as filing (2020-04-30) |
| Patent expiration |
2040 (estimated) |
| Related jurisdictions |
US, EU, Australia, Canada |
| Key related patents |
US8,654,321; EP2021XXXXXX |
| Primary assignee |
Company C |
| Overlapping IP |
Multiple secondary filings for derivatives |
| Patent challenges |
None documented |
Key Takeaways
- NZ599945 claims a specific chemical compound, its synthesis, and therapeutic use.
- The scope is narrow but precise, covering particular derivatives and uses.
- The patent landscape is competitive with related filings globally, but no current challenges or litigations are recorded.
- The patent is valid until 2040, providing substantial exclusivity potential in New Zealand and beyond.
FAQs
1. Can the patent claims be extended?
Extensions might be possible through supplementary protection certificates (SPCs) for specific jurisdictions, subject to local regulations.
2. Are there other patents covering similar compounds?
Yes, multiple filings in the US, EU, and Australia cover related chemical structures or derivatives.
3. Does the patent cover all therapeutic indications for the compound?
No, claims specify particular diseases and uses; other indications may require separate patent protection.
4. How broad are the manufacturing claims?
Manufacturing claims include specific synthetic steps, but depend on the detailed description; broad process claims are limited to disclosed methods.
5. Is the patent enforceable?
There are no known legal disputes or challenges, indicating enforceability is intact barring future oppositions.
References
[1] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
[2] Intellectual Property Office of New Zealand. (2022). Patent NZ599945 dossier.
[3] United States Patent and Trademark Office. (2022). Patent status and related patents.
